MBC and ECBL libraries: outstanding tools for drug discovery
Frontiers in Pharmacology · 11.08.2023 · 14
DOI: 10.3389/fphar.2023.1244317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 11.08.2023. Verfasst von Tiziana Ginex und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigaciones Biológicas "Margarita Salas" (CIB-CSIC), Madrid, Spain. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación, Ministerio de Educación y Cultura, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Chemical libraries have become of utmost importance to boost drug discovery processes. It is widely accepted that the quality of a chemical library depends, among others, on its availability and chemical diversity which help in rising the chances of finding good hits. In this regard, our group has developed a source for useful chemicals named Medicinal and Biological Chemistry (MBC) library. It originates from more than 30 years of experience in drug design and discovery of our research group and has successfully provided effective hits for neurological, neurodegenerative and infectious diseases. Moreover, in the last years, the European research infrastructure for chemical biology EU-OPENSCREEN has generated the European Chemical Biology library (ECBL) to be used as a source of hits for drug discovery. Here we present and discuss the updated version of the MBC library (MBC v.2022), enriched with new scaffolds and containing more than 2,500 compounds together with ECBL that collects about 100,000 small molecules. To properly address the improved potentialities of the new version of our MBC library in drug discovery, up to 44 among physicochemical and pharmaceutical properties have been calculated and compared with those of other well-known publicly available libraries. For comparison, we have used ZINC20, DrugBank, ChEMBL library, ECBL and NuBBE along with an approved drug library. Final results allowed to confirm the competitive chemical space covered by MBC v.2022 and ECBL together with suitable drug-like properties. In all, we can affirm that these two libraries represent an interesting source of new hits for drug discovery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro de Investigaciones Biológicas "Margarita Salas" (CIB-CSIC), Madrid, Spain.
- Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Förderung
- Agencia Estatal de Investigación
- Ministerio de Educación y Cultura
- Horizon 2020 Framework Programme
Zitieren
APA
Ginex, T., Madruga, E., Martinez, A., & Gil, C. (2023). MBC and ECBL libraries: outstanding tools for drug discovery. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1244317
Vancouver
Ginex T, Madruga E, Martinez A, Gil C. MBC and ECBL libraries: outstanding tools for drug discovery. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1244317
BibTeX
@article{Ginex2023,
author = {Ginex, Tiziana and Madruga, Enrique and Martinez, Ana and Gil, Carmen},
title = {MBC and ECBL libraries: outstanding tools for drug discovery},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1244317}
}
EUVIMED